Michael Zinda, EVP, Chief Science Officer at Repare Therapeutics Inc. (RPTX), sold 15,000 shares at $33.97 ($510K) on 2021-08-16, disclosed to the SEC on 2021-08-20.
Open-market sale of $510k RPTX by EVP, Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.97 | 14,300 | $486K | 95.3% |
| 2 | $34.45 | 700 | $24K | 4.7% |
| Total | $33.99 avg | 15,000 | $510K | 100% |
| Filing → |
| RPTX | SELL | 2024-03-27 | $6K | — | Filing → |
| RPTX | SELL | 2023-06-09 | $189K | — | Filing → |
| RPTX | SELL | 2023-06-07 | $14K | — | Filing → |